1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis initiative highlights rare skin disease research as a priority area, encouraging investigator-initiated applications to address urgent gaps in knowledge and treatment for rare skin disorders.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigators should apply through an appropriate NIH Parent Funding Announcement or another broad NIH opportunity available on Grants. gov. Multidisciplinary teams are encouraged. Confirm the full requirements in the official notice before applying.
The current listing shows budget and duration determined by the selected NIH parent funding opportunity; typical NIH R01 budgets apply (e.g., up to $500,000/year in direct costs, 3–5 years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for NIH Highlights Rare Skin Disease Research as a Priority Area are due April 2, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NIH Highlights Rare Skin Disease Research as a Priority Area is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other NIH Institutes, Centers, and Offices (ICOs). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Advancing Research into the Cause and Treatment of Rare Skin Diseases is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Center for Advancing Translational Sciences (NCATS), National Institute of Environmental Health Sciences (NIEHS) (NIH). This NIH highlighted topic aims to facilitate research on rare skin diseases, with a focus on projects involving multidisciplinary teams of basic, translational, and clinical scientists.
NIH Highlighted Topic: Rare Skin Disease Research is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Center for Advancing Translational Sciences (NCATS), National Institute of Environmental Health Sciences (NIEHS), Office of Research on Women's Health (ORWH). This is not a specific notice of funding opportunity but rather an encouragement from multiple NIH institutes for investigator-initiated applications addressing rare skin diseases.
ARPA-H launched SPECTRA on September 17, 2026 under solicitation ARPA-H-SOL-26-163 — four technical areas with separate Solution Summary deadlines on October 18, December 2, and January 18. The enabling-technologies area closes first, five weeks after launch. Here is why the sequencing matters and how to read each TA.
Read articlePA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read article